Adverse events reported with BPaL and BPaLM regimens in drug-resistant tuberculosis [0.03%]
BPaL及其衍生方案治疗耐多药结核病的安全性分析
Kannan Sridharan,Gowri Sivaramakrishnan
Kannan Sridharan
Refractory splenic tuberculosis in acute myeloid Leukemia: The role of advanced diagnostics and surgical intervention [0.03%]
急性髓系白血病并发难治性脾结核的诊断和手术治疗经验
Hongju Yan,Qin Wen,Xi Zhang
Hongju Yan
AML patients are at a high risk of opportunistic infections, with tuberculosis (TB) being a common and challenging one. The immunosuppression caused by both AML and its treatment heightens this risk. Diagnosing TB in AML patients is difficu...
Atypical presentations of mucocutaneous TB in HIV: A case series from South Africa [0.03%]
南非HIV感染者黏膜皮肤结核的不典型表现：一系列病例报告
Mahlatse Cordelia Kgokolo,Mohlominyane Jeffrey Mokheseng,Jabulile Johanna Makhubele et al.
Mahlatse Cordelia Kgokolo et al.
Introduction: Tuberculosis (TB) remains a major burden of disease worldwide, especially in Human immunodeficiency virus (HIV)-infected patients. Cutaneous forms of TB account for approximately 10 % of all extrapulmonary t...
Rifampicin-resistant Mycobacterium tuberculosis and unsuccessful results from Xpert® MTB/Rif-Ultra assay in Amhara Region, Ethiopia [0.03%]
埃塞俄比亚阿姆哈拉地区利福平耐药性结核分枝杆菌及Xpert® MTB/RIF Ultra检测失败结果的研究
Gizeaddis Belay,Hailu Getachew,Tigist Birku et al.
Gizeaddis Belay et al.
Background: Tuberculosis, an infectious disease caused by Mycobacterium tuberculosis (Mtb), causes 10 million new infections and 1.3 million deaths annually. The treatment of TB is hampered by the increasing incidence rat...
Mycobacterium shimoidei cavitary pneumonia : A rare case report, literature review [0.03%]
Shimode氏分枝杆菌空洞型肺炎一例及文献复习
Siddartha Guru,David Ingram
Siddartha Guru
Mycobacterium shimoidei is a rare non-tuberculous mycobacterium (NTM) which causes pneumonia. Since its discovery in 1975, less than 50 cases have been published and this would be only the fourth case in the US. We present a case of Mycobac...
Estimation of therapeutic threshold for tuberculosis using adapted nominal group technique and clinical vignettes in clinical and community settings in Southern Africa [0.03%]
在南部非洲的临床和社区环境中使用适应名义群体技术和临床情节估算结核病治疗阈值的方法学论文
Alfred Kipyegon Keter,Alastair Van Heerden,Tom Decroo et al.
Alfred Kipyegon Keter et al.
Background: When confronted with diagnostic uncertainty and a decision on whether to start treatment or not, clinicians consider the potential harm and benefit of offering versus withholding treatment. Treatment can be of...
Bridging gaps in tuberculosis control: addressing cross-border challenges between India and Pakistan [0.03%]
印度与巴基斯坦结核病控制跨境挑战及应对措施
Harendra Kumar,Fnu Teena,Aneeta Bai et al.
Harendra Kumar et al.
Tuberculosis (TB) continues to pose a substantial public health concern in South Asia, especially in India and Pakistan, which together represent a considerable portion of the worldwide TB burden. Notwithstanding national initiatives, inter...
Epidemiology of nontuberculous mycobacteria in the Finger Lakes region of New York [0.03%]
纽约手指湖地区非结核分枝杆菌的流行病学研究
Michael Croix,Ghinwa Dumyati,Alexandra Adams et al.
Michael Croix et al.
Clinical-epidemiologic data for all nontuberculous mycobacteria isolated in the 9 County Finger Lakes region of NY from 226 patients between 04/01/2018-03/31/2020 were retrospectively analyzed. Only 51% of patients meeting diagnostic criter...
Association of prior tuberculosis with altered cardiometabolic profiles of people with HIV: A comparative cross-sectional study in Uganda [0.03%]
结核病史与艾滋病毒感染者的心血管代谢特征改变之间的关联：乌干达一项比较性横断面研究
Joseph Baruch Baluku,Diana Karungi,Brenda Namanda et al.
Joseph Baruch Baluku et al.
Background: Cardiovascular disease (CVD) is the leading cause of mortality among people with HIV (PWH), but the influence of co-infections like tuberculosis (TB) on CVD risk remains underexplored. We aimed to compare card...
Hematochemical hallmarks as markers of pulmonary TB severity: A multicenter cross-sectional study [0.03%]
血生化标志物作为肺结核严重程度的标记：一项多中心横断面研究
Francesco Di Gennaro,Giacomo Guido,Sergio Cotugno et al.
Francesco Di Gennaro et al.
Background: Identifying accessible and reliable biomarkers for tuberculosis (TB) severity is crucial for improving patient management. This study evaluates hematological findings as potential indicators of TB severity in ...